BIOMAT Database Logo BIOMAT Database Logo

In-vitro activity of sparfloxacin, pefloxacin, ciprofloxacin and temafloxacin against clinical isolates of Acinetobacter spp. 1992

M L Joly-Guillou, and E Bergogne-Bérézin

UI MeSH Term Description Entries
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D000150 Acinetobacter A genus of gram-negative bacteria of the family MORAXELLACEAE, found in soil and water and of uncertain pathogenicity. Herellea,Mima
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone
D015366 Pefloxacin A synthetic broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria. 2589 R.B.,Abactal,Peflacine,Pefloxacin Mesylate,Pefloxacin Mesylate Dihydrate,Pefloxacine,Silver Pefloxacin,Dihydrate, Pefloxacin Mesylate,Mesylate Dihydrate, Pefloxacin,Mesylate, Pefloxacin,Pefloxacin, Silver,R.B., 2589
D024841 Fluoroquinolones A group of QUINOLONES with at least one fluorine atom and a piperazinyl group. Fluoroquinolone

Related Publications

M L Joly-Guillou, and E Bergogne-Bérézin
Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
April 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
M L Joly-Guillou, and E Bergogne-Bérézin
[In vitro activity of 11 antimicrobial agents against clinical isolates of Acinetobacter spp].
May 1992, Enfermedades infecciosas y microbiologia clinica,
M L Joly-Guillou, and E Bergogne-Bérézin
Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
April 1987, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology,
M L Joly-Guillou, and E Bergogne-Bérézin
In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans.
February 2000, The Journal of antimicrobial chemotherapy,
M L Joly-Guillou, and E Bergogne-Bérézin
Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria.
May 1992, Antimicrobial agents and chemotherapy,
M L Joly-Guillou, and E Bergogne-Bérézin
In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.
July 1993, Diagnostic microbiology and infectious disease,
M L Joly-Guillou, and E Bergogne-Bérézin
In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.
November 2006, International journal of antimicrobial agents,
M L Joly-Guillou, and E Bergogne-Bérézin
In vitro activity of trovafloxacin versus ciprofloxacin against clinical isolates.
August 1996, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
M L Joly-Guillou, and E Bergogne-Bérézin
In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea.
March 2009, International journal of antimicrobial agents,
M L Joly-Guillou, and E Bergogne-Bérézin
In vitro activity of ceftobiprole against Acinetobacter baumannii clinical isolates.
September 2009, International journal of antimicrobial agents,
Copied contents to your clipboard!